Cidara Therapeutics is a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing cancer and other serious diseases.
View Top Employees from Cidara TherapeuticsWebsite | http://www.cidara.com/ |
Ticker | CDTX |
Revenue | $54.3 million |
Funding | $278.5 million |
Employees | 95 (95 on RocketReach) |
Founded | 2013 |
Address | 6310 Nancy Ridge Drive Suite 101, San Diego, California 92121, US |
Phone | (858) 752-6170 |
Technologies |
JavaScript,
HTML,
PHP
+50 more
(view full list)
|
Category | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Health Care, Therapeutics |
Web Rank | 4 Million |
Keywords | cdtx, cidara therapeutics inc, gram negative bacteria infections, cidara, cidara thera |
Competitors | Aridis Pharmaceutical, Checkmate Pharmaceuticals, Eiger BioPharmaceuticals, SCYNEXIS, Inc., Venatorx Pharmaceuticals, Inc. |
SIC | 28, 283 |
NAICS | 541, 541711, 5417, 54, 54171, 3254, 32541, 32, 325414, 325 |
Looking for a particular Cidara Therapeutics employee's phone or email?
The Cidara Therapeutics annual revenue was $54.3 million in 2023.
Ken Bartizal is the Chief Development Officer of Cidara Therapeutics.
95 people are employed at Cidara Therapeutics.
Cidara Therapeutics is based in San Diego, California.
The NAICS codes for Cidara Therapeutics are [541, 541711, 5417, 54, 54171, 3254, 32541, 32, 325414, 325].
The SIC codes for Cidara Therapeutics are [28, 283].